Safety of systemic therapies in the treatment of psoriasis with concomitant cirrhosis: a retrospective study

Int J Dermatol. 2019 Nov;58(11):e228-e229. doi: 10.1111/ijd.14556. Epub 2019 Jul 23.

Authors

Alecia M Blaszczak¹, Spencer Dunaway², Mirza Ali Alikhan³, Sean Kelly¹, Douglas Levin¹, Jessica Kaffenberger¹

Affiliations

¹ The Ohio State University Wexner Medical Center, Columbus, OH, USA.
² The University of Cincinnati Medical Center, Cincinnati, OH, USA.
³ Sutter Medical Foundation, Sacramento, CA, USA.

PMID: 31334835
DOI: 10.1111/ijd.14556

No abstract available

Publication types

Letter

MeSH terms

Aged
Dermatologic Agents / administration & dosage
Dermatologic Agents / adverse effects*
Female
Humans
Liver / drug effects*
Liver / physiopathology
Liver Cirrhosis / blood
Liver Cirrhosis / complications*
Liver Cirrhosis / physiopathology
Liver Function Tests
Male
Middle Aged
Psoriasis / blood
Psoriasis / complications
Psoriasis / drug therapy*
Retrospective Studies
Treatment Outcome
Ustekinumab / administration & dosage
Ustekinumab / adverse effects*

Substances

Dermatologic Agents
Ustekinumab